Met and HGF inhibition in triple-negative breast cancer cell lines

被引：0
作者：
Gaule, Patricia Brid
Collins, Denis
Walsh, Naomi
Duffy, Michael J.
Crown, John
O'Donovan, Norma
机构：
[1] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Clin Res Ctr, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[4] Dublin City Univ, Dublin 9, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066
引用
收藏
页数：1
相关论文
共 50 条
[41]   Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin [J].
Hastak, Kedar ;
Alli, Elizabeth ;
Ford, James M. .
CANCER RESEARCH, 2010, 70 (20) :7970-7980
[42]   Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines [J].
Ibrahim, Toni ;
Liverani, Chiara ;
Mercatali, Laura ;
Sacanna, Emanuele ;
Zanoni, Michele ;
Fabbri, Francesco ;
Zoli, Wainer ;
Amadori, Dino .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (04) :1263-1270
[43]   Effect of afatinib alone and in combination with dasatinib in triple-negative breast cancer cell lines. [J].
Ibrahim, Mohamed F. K. ;
Canonici, Alexandra ;
Collins, Denis ;
Crown, John ;
O'Donovan, Norma .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[44]   Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines [J].
Lavender, Nicole A. ;
Chow, Donald ;
Yin, Holly ;
Berens, Michael E. ;
Carpten, John D. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
[45]   Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple-Negative Breast Cancer Cell Lines [J].
Wong, Fu Hou ;
Palanirajan, Vijayaraj Kumar ;
Ng, Edmond Siah Chye ;
Tan, Chung Keat ;
Tan, Eugenie Sin Sing ;
Amini, Farahnaz .
PHARMACEUTICALS, 2022, 15 (09)
[46]   Classification of molecular subtypes of triple-negative breast cancer cell lines using two models [J].
Fernandez, Jose Rodrigo Espinosa ;
Eckhardt, Bedrich L. ;
Lee, Jangsoon ;
Seitz, Robert S. ;
Hout, David R. ;
Ring, Brian Z. ;
Lim, Bora ;
Ueno, Naoto T. .
CANCER RESEARCH, 2018, 78 (04)
[47]   Vorinostat modulates the expression of the progesterone receptor in subtypes of triple-negative breast cancer cell lines [J].
Lyn-Cook, Beverly ;
NouriEmamzadeh, Fatemeh ;
Word, Beverly ;
Moore, Rhonda ;
Miranda-Carboni, Gustav .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) :131-131
[48]   Inhibition of BCL2 and XPO1 demonstrates synergistic effects in triple-negative breast cancer cell lines [J].
Jackson, Marilyn Marie ;
Smoots, Stephen G. ;
Dominguez, Adrian T. ;
Dus, Evan ;
Bagby, Stacey ;
Binns, Cameron ;
Pitts, Todd M. ;
Diamond, Jennifer R. .
CANCER RESEARCH, 2024, 84 (06)
[49]   Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines [J].
Lavender, Nicole A. ;
Chow, Donald ;
Yin, Holly ;
Carpten, John .
CANCER RESEARCH, 2014, 74 (19)
[50]   Advanced Triple-Negative Breast Cancer [J].
Patel, Grisma ;
Prince, Alison ;
Harries, Mark .
SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
12345